Blood levels of neuroleptic drugs in nonresponding chronic schizophrenic patients.
Blood levels of butaperazine were measured in schizophrenic patients who were chronic nonresponders to their psychotropic medication. The blood levels were compared with those in patients who had shown a better clinical response to this neuroleptic. Nonresponders had two to seven times lower levels of butaperazine in plasma and RBCs after a single dose or chronic dosing. Some of the patients later treated with thioridazine or haloperidol had lower plasma levels of these neuroleptics also. No significant differences were found between nonresponders and relative responders in either the alpha- or beta-phase half-life of butaperazine in plasma and RBCs after administration of a single dose of the drug. Butaperazine and thioridazine levels were not related to previously administered amounts of neuroleptic drugs. These findings do not support the hypothesis that low blood levels are the result of faster systemic metabolism of the drug after it reaches the central circulation. Our results suggest that low blood levels of neuroleptics may be one important factor in the poor clinical response of some chronic schizophrenic patients.
D000328:Adult; D014150:Antipsychotic Agents / Q000097:blood* / Q000378:metabolism / Q000627:therapeutic use; D001702:Biopharmaceutics; D002908:Chronic Disease; D004305:Dose-Response Relationship, Drug; D004912:Erythrocytes / Q000032:analysis; D005260:Female; D006207:Half-Life; D006220:Haloperidol / Q000097:blood / Q000378:metabolism / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D010640:Phenothiazines / Q000097:blood / Q000378:metabolism / Q000627:therapeutic use; D012559:Schizophrenia / Q000097:blood / Q000188:drug therapy*; D013881:Thioridazine / Q000097:blood / Q000378:metabolism / Q000627:therapeutic use
D014150:Antipsychotic Agents; D010640:Phenothiazines; D006220:Haloperidol; D013881:Thioridazine